Beijing Bohui Innovation Biotechnology Group (300318.SZ): The company's Yunnan blood product factory has been completed and is currently pushing forward various process works.

On December 23, Glonghui reported that Beijing Bohui Innovation Biotechnology Group (300318.SZ) stated on the investor interaction platform that the Yunnan blood product factory has been completed. The company is currently advancing the product process validation, changes in the pharmaceutical marketing authorization holder, production site and pharmaceutical research, and change approvals in accordance with the "Measures for the Administration of Changes After Drug Marketing" and other relevant normative documents and technical guidance principles. The company is currently unable to accurately predict the completion time for all processes and the specific start time for production.

Gelonghui FinanceDec 23, 2024 15:33

Beijing Bohui Innovation Biotechnology Group (300318.SZ): Currently, there are no food safety-related testing products available.

On November 29, Beijing Bohui Innovation Biotechnology Group (300318.SZ) stated on the investor interaction platform that the company currently has no food safety related testing products.

Gelonghui FinanceNov 29, 2024 15:21

Beijing Bohui Innovation Biotechnology Group (300318.SZ): The microfluidic chip used in the company's in vitro diagnostic test reagents is developed and manufactured by the company.

Gelonghui October 31st - Beijing Bohui Innovation Biotechnology Group (300318.SZ) stated on the investor interaction platform that the microfluidic chip used in the company's in vitro diagnostic test reagents is developed and manufactured by the company. Its main purpose is as a liquid reagent carrier, driving the pump valve on the chip through the instrument's gas path module to achieve the directional flow of liquid reagents in the chip, completing the sample extraction, PCR amplification, DNA reverse hybridization, and other detection processes. The microfluidic chip is used in conjunction with the company's detection analyzers to achieve automated testing of molecular diagnostic reagents.

Gelonghui FinanceOct 31, 2024 17:37

Bohui Innovation: 2024 Third Quarter Report

SZSIOct 30, 2024 00:00 · Announcements

beijing bohui innovation biotechnology group (300318.SZ) released net income for the first three quarters, with a net income of 23.7177 million yuan, an increase of 67.77%.

beijing bohui innovation biotechnology group (300318.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters was 6...

Zhitong FinanceOct 29, 2024 22:55

Beijing Bohui Innovation Biotechnology Group (300318.SZ): The net income in the first three quarters was 23.7177 million yuan, a year-on-year increase of 67.77%.

Gelonghui on October 29th ǀ Beijing Bohui Innovation Biotechnology Group (300318.SZ) released the third quarter report for 2024, with the company achieving a revenue of 0.646 billion yuan in the first three quarters, a 19.85% year-on-year decrease; a net income attributable to shareholders of the listed company of 23.7177 million yuan, a 67.77% year-on-year increase; a net income attributable to shareholders of the listed company excluding non-recurring gains and losses of 15.6564 million yuan, a 29.24% year-on-year increase; and an earnings per share of 0.0290 yuan.

Gelonghui FinanceOct 29, 2024 18:02